CB43829-21 - 0x000000000000658F

Overweight Males & Females

Cardinal

* Stipend may pay up to reflected amount.
Start Date: 
March 11, 2025 - 3:00pm
End Date: 
May 1, 2025 - 9:30am

Study Details

Study Number: CB43829
Group Number: 21
Study Requirement: Obese
Stipend: up to $9,000.00

Study Criteria

Age: 19 - 55
BMI: 27 - 39.9
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat obesity.
Route of Administration: Injection subcutaneous
Blood Draws: 21

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 3 Night Stay, Two - 2 Night Stays, One - 5 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Monday 2/17/2025
Thursday 2/20/2025
Monday 3/3/2025
Friday 3/7/2025

Doctor Exam Dates:

Event Day Event Date
Monday 2/17/2025
Thursday 2/20/2025
Monday 3/3/2025
Friday 3/7/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 3/11/2025 3:00:00 PM Friday 3/14/2025 10:00:00 AM 1 Lincoln
Check-In Wednesday 3/19/2025 7:00:00 AM Friday 3/21/2025 10:00:00 PM 1 Lincoln
Check-In Wednesday 3/26/2025 7:00:00 AM Friday 3/28/2025 10:00:00 PM 1 Lincoln
Check-In Wednesday 4/2/2025 7:00:00 AM Monday 4/7/2025 10:00:00 AM 1 Lincoln
Return Wednesday 4/9/2025 7:30:00 AM Wednesday 4/9/2025 9:30:00 AM 1 Lincoln
Return Saturday 4/12/2025 8:30:00 AM Saturday 4/12/2025 9:30:00 AM 1 Lincoln
Return Wednesday 4/16/2025 8:30:00 AM Wednesday 4/16/2025 9:30:00 AM 1 Lincoln
Return Wednesday 4/23/2025 8:30:00 AM Wednesday 4/23/2025 9:30:00 AM 1 Lincoln
Return Thursday 5/1/2025 7:30:00 AM Thursday 5/1/2025 9:30:00 AM 1 Lincoln